hAAT (80 mg/kg/day; i.p.) treatment decreases acute tubular necrosis after I/R Injury (IRI). by Nuria Maicas (109242)

Increased body fat, glucose and PAI-1 and decreased adiponectin levels in 6 wk old WT offspring exposed to HF IU/L. by Patricia M. Vuguin (587226)

Decreased postprandial TG secretion, intestinal TG hydrolase activity, and intestinal fatty acid oxidation in intestine-specific CGI-58 knockout mice. by Ping Xie (112003)

Maternal immunization with the <i>Lamp/gag</i> DNA vaccine decreases anti-Gag IgG1 Ab production in immunized offspring. by Paula Ordonhez Rigato (183494)

Primers sequences (5’- 3’). by Xinyue Bai (13720877)

“…Eight-week-old male wild type (WT) mice and GCN2 knock out (KO) mice were randomly divided into WT control (n = 6), WT exercise(n = 5), GCN2 KO control(n = 5), and GCN2 KO exercise(n = 5) groups. …”

Fig 2 - by Lucas H. Oronel (8525697)

Kinin B₁R inhibition or genetic deletion decreased the level of inflammatory cell infiltration and the demyelination area in experimental EAE. by Rafael C. Dutra (205755)

HSP90B1 and CALM1 were increased, but ANXA6 and TPM2 were decreased, in tissues from patients with PCOS. by Li Li (14993)

Phosphorylated ERK (ERK-P) is decreased in terminally prion-diseased PrP^CGPIThy-1 L150 mice. by Berta Puig (344828)

“…Note that there is a significant decrease in ERK-P signal (*<i>p</i> = 0.031) in PrP^CGPIThy-1 RML infected mice compared to WTPrP^C mice, whereas no changes are observed for p38-P.…”

<i>Zfp92</i> KO mice have increased blood glucose and decreased <i>Mafb</i> and insulin expression at P1. by Anna B. Osipovich (8742198)

Sequences of the qPCR primers used. by Lucas H. Oronel (8525697)

“…This increase was mainly cytoplasmic, explaining the increased urinary volume of CKD rats and suggesting a possible non-canonical role for AQP2. In addition, Tolvaptan effectively inhibited the V2 receptor in both control and CKD rats, decreasing AQP2 expression and increasing diuresis. …”

Original and uncropped blots. by Lucas H. Oronel (8525697)

“…This increase was mainly cytoplasmic, explaining the increased urinary volume of CKD rats and suggesting a possible non-canonical role for AQP2. In addition, Tolvaptan effectively inhibited the V2 receptor in both control and CKD rats, decreasing AQP2 expression and increasing diuresis. …”

Chestnut extract but not sodium salicylate decreases the severity of diarrhea and enterotoxigenic <i>Escherichia coli</i> F4 shedding in artificially infected piglets by M. Girard (8501361)

“…Feed additives, including bioactive compounds, could be a promising alternative. This study aimed to test two bioactive compounds, sodium salicylate (SA) and a chestnut extract (CE) containing hydrolysable tannins, on the occurrence of PWD. …”

DataSheet5.pdf by Neha Thakre (4864348)

Supplemental Tables S1-S5 by Kevin Gries (21956942)

DDX5 and DDX17 localize to the nucleus in iSLK.219 and TREx-BCBL1-RTA cells upon lytic reactivation. by Praneet Kaur Sandhu (21156149)

SupplementaryData5.PPT by Elena Silvestri (354706)

“…The administration of the naturally occurring metabolite 3,5-diiodo-L-thyronine (T2) with thyromimetic actions to high fat diet (HFD)-fed rats exerts a systemic hypolipidemic effect, which produces a lack of IMCL accumulation, a shift toward glycolytic fibers and amelioration of insulin sensitivity in gastrocnemius muscle. …”

Fluorofenidone decreased p22^phox expression in the kidney of <i>db/db</i> mice at earlier stages of DN development. by Xuan Xiong (649607)

data_sheet_5.xlsx by Ji Chen (69329)

Data_Sheet_5.XLSX by Behzad Bidadi (4953235)

“…We previously performed a genome-wide association study (GWAS) for neutropenia events in women with breast cancer who were treated with 5-fluorouracil, epirubicin and cyclophosphamide and recruited to the SUCCESS-A trial. …”